Abby Colson
@arcolson
Followers
44
Following
14
Media
0
Statuses
12
Lecturer in Management Science at the University of Strathclyde. Health economics. Policy evaluation. Risk and uncertainty analysis.
Joined July 2019
A great opportunity for a fully-funded three-year PhD scholarship @StrathManSci with @arcolson and John Quigley on “Experts, Analogies & Data: Modelling Uncertainty based on Expert Understanding of Analogous Events” – see link for more info and to apply https://t.co/CVJEU9CsT2
0
3
2
Our @StrathManSci colleague @arcolson will be speaking at the next session of the Glasgow Health Economics Seminar Series on Monday (22nd Nov) with @HEHTAGlasgow – looks like a really interesting session
We're looking forward to having HEHTA's @Ryan_J_Field, Dr Neil McHugh from @YunusCentreGCU & Dr @Abigail Colson @UniStrathclyde present on Monday 22 Nov. as part of our Glasgow Health Economics Seminar Series (GhESS)!
0
4
1
We need to pay for the social value of antibacterials, which requires updating reimbursement rules. New article from A.R. Colson, et al in Value in Health @AllianceBEAM @AndersonJames34 @LeonardColm @UKAMREnvoy
valueinhealthjournal.com
Antimicrobial resistance is a serious challenge to the success and sustainability of our healthcare systems. There has been increasing policy attention given to antimicrobial resistance in the last...
1
6
15
Great session from @VijayaNath1 today and lots of great discussion in the breakouts. #IAmAurora
.Thanks for being so great to work with #IAmAurora #PoliticsAndInfluence here is a helpful resource - have a great rest of the day and programme
0
0
4
How should HTA consider new antibiotics? The latest @DRIVE_AB paper from us and @CDDEP colleagues: https://t.co/SFhPQ1QgCj
@StrathclydeOA @IMI_JU
0
1
1
After making the case for the potential value of expert judgements in this area, it's great to see our paper out in @PLOSONE now! @IMegiddo @CDDEP
Expert & statistical projections of resistance rates in 4 EU countries suggests stewardship and infection control will bend the curve, away from the worst case scenarios in the AMR Review https://t.co/LKrR5W2zD8 See this as an opportunity to deliver on national action plans
0
0
1
0
0
0
Loving the combined message of these two articles. 1. @TheEconomist: A future without antibiotics is bleak.
1
0
0
Exciting news from the UK!
Today we’ve launched a world-leading drive to incentivise pharmaceutical companies to develop new drugs for resistant infections (1/5) #AMR
https://t.co/b5VJ7MhsM4
0
0
0